JP2024544067A5 - - Google Patents

Info

Publication number
JP2024544067A5
JP2024544067A5 JP2024532266A JP2024532266A JP2024544067A5 JP 2024544067 A5 JP2024544067 A5 JP 2024544067A5 JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024544067 A5 JP2024544067 A5 JP 2024544067A5
Authority
JP
Japan
Application number
JP2024532266A
Other languages
Japanese (ja)
Other versions
JP2024544067A (ja
JPWO2023099494A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/083711 external-priority patent/WO2023099494A1/en
Publication of JP2024544067A publication Critical patent/JP2024544067A/ja
Publication of JP2024544067A5 publication Critical patent/JP2024544067A5/ja
Publication of JPWO2023099494A5 publication Critical patent/JPWO2023099494A5/ja
Pending legal-status Critical Current

Links

JP2024532266A 2021-11-30 2022-11-29 Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso) Pending JP2024544067A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21211372.4 2021-11-30
EP21211372 2021-11-30
PCT/EP2022/083711 WO2023099494A1 (en) 2021-11-30 2022-11-29 Antisense oligonucleotides (aso) for efficient and precise rna editing with endogenous adenosine deaminase acting on rna (adar)

Publications (3)

Publication Number Publication Date
JP2024544067A JP2024544067A (ja) 2024-11-27
JP2024544067A5 true JP2024544067A5 (https=) 2025-12-11
JPWO2023099494A5 JPWO2023099494A5 (https=) 2025-12-11

Family

ID=78820190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532266A Pending JP2024544067A (ja) 2021-11-30 2022-11-29 Rnaに作用する内因性アデノシンデアミナーゼ(adar)による効率的および正確なrna編集のためのアンチセンスオリゴヌクレオチド(aso)

Country Status (9)

Country Link
US (1) US20230235329A1 (https=)
EP (1) EP4441216A1 (https=)
JP (1) JP2024544067A (https=)
KR (1) KR20240111752A (https=)
CN (1) CN118355119A (https=)
AU (1) AU2022399905A1 (https=)
CA (1) CA3238033A1 (https=)
IL (1) IL312762A (https=)
WO (1) WO2023099494A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024114908A1 (en) * 2022-11-30 2024-06-06 Eberhard Karls Universität Tübingen Chemically modified antisense oligonucleotides (asos) and compositions comprising the same for rna editing
AU2024325709A1 (en) * 2023-08-15 2026-01-29 Airna Corporation Chemically modified antisense oligonucleotides (asos) and compositions for rna editing
WO2025073902A1 (en) * 2023-10-06 2025-04-10 Eberhard Karls Universität Tübingen Chemical and sequence optimisation of antisense oligonucleotides for adar-mediated rna editing
WO2025172372A1 (en) 2024-02-12 2025-08-21 Airna Corporation Conjugate for targeted delivery of an antisense oligonucleotide
WO2025242018A1 (zh) * 2024-05-20 2025-11-27 时夕(广州)生物科技有限公司 一种经修饰的向导agRNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10941402B2 (en) 2016-09-01 2021-03-09 Proqr Therapeutics Ii B.V. Chemically modified single-stranded RNA-editing oligonucleotides
WO2020001793A1 (en) 2018-06-29 2020-01-02 Eberhard-Karls-Universität Tübingen Artificial nucleic acids for rna editing
CA3158528A1 (en) * 2019-12-23 2021-07-01 Jim SWILDENS Antisense oligonucleotides for nucleotide deamination in the treatment of stargardt disease

Similar Documents

Publication Publication Date Title
JP2024544067A5 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
CN307049516S (https=)
BY13152U (https=)
CN307046380S (https=)
CN307046060S (https=)
CN307045560S (https=)
CN307044813S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13161U (https=)
BY13160U (https=)